News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Pierre Morgon

Advertisement

Articles by Pierre Morgon

line-853396-1416900173890.gif

Medical Affairs: From Info Gatekeeper to Legitimate Value Driver

ByPierre Morgon
September 1st 2014

The role of pharma medical affairs teams is taking on greater importance in the value chain.

Advertisement

Latest Updated Articles

  • line-853396-1416900173890.gif
    Medical Affairs: From Info Gatekeeper to Legitimate Value Driver

    Published: September 1st 2014 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

Report: Richard Pazdur Out as Director of CDER

2

Pharmaceutical Commercialization: A 2026 Outlook Personalization and Precision Will Define a New Year in Pharma

3

Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients

4

Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy

5

Patients Avoid Care as Healthcare Costs Rise: Report

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us